eXoZymes Inc(EXOZ)

11.75+0.36+3.16%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
  GlobeNewswire · 04-10
  BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
- eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
  GlobeNewswire · 04-02
  eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
- eXoZymes Provides Fourth Quarter and Full Year 2024 Update
  GlobeNewswire · 04-02
  eXoZymes Provides Fourth Quarter and Full Year 2024 Update
- MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
  GlobeNewswire · 03-31
  MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
- eXoZymes Inc trading halted, volatility trading pause
  TIPRANKS · 03-17
  eXoZymes Inc trading halted, volatility trading pause
- New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce
  ACCESS Newswire · 03-04
  New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce
- Leadership Transition Announced at eXoZymes, MDB CEO Marlett Named Chairman
  Dow Jones · 02-21
  Leadership Transition Announced at eXoZymes, MDB CEO Marlett Named Chairman
- eXoZymes president, chairman Hayat transitions out of roles
  TIPRANKS · 02-21
  eXoZymes president, chairman Hayat transitions out of roles
- Exozymes Inc: Christopher Marlett Will Assume Role of Chairman
  THOMSON REUTERS · 02-21
  Exozymes Inc: Christopher Marlett Will Assume Role of Chairman
- Exozymes Inc: Mo Hayat Transitioned Out of His Roles as Chairman of Board and President
  THOMSON REUTERS · 02-21
  Exozymes Inc: Mo Hayat Transitioned Out of His Roles as Chairman of Board and President
- eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
  GlobeNewswire · 02-21
  eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
- eXoZymes Inc trading resumes
  TIPRANKS · 02-19
  eXoZymes Inc trading resumes
- eXoZymes Inc trading halted, volatility trading pause
  TIPRANKS · 02-19
  eXoZymes Inc trading halted, volatility trading pause
- Exozymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
  THOMSON REUTERS · 02-19
  Exozymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
- Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)
  Simply Wall St. · 02-13
  Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)
- Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
  GlobeNewswire · 02-12
  Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
Company Profile
Company Name
eXoZymes Inc
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.invizyne.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
- -
- 04-02
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 04-02
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 03-31
  Annual Report
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-21
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 02-11
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-18
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-18
  Beneficial Ownership Change
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  Beneficial Ownership Change
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  Beneficial Ownership Change
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-18
  Beneficial Ownership Change
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
  Form SC 13D - General Statement of Acquisition of Beneficial Ownership
- 2024-11-12
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-06
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-11-06
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-31
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-25
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence

1D
5D
Day
Week
Month

Loading ...

High

11.75

Open

11.08

Volume%

0.48

Low

11.02

11.39

T/O Rate

0.03%

eXoZymes Inc(EXOZ)

Company Profile